GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amarantus Bioscience Holdings Inc (OTCPK:AMBS) » Definitions » 14-Day RSI

Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) 14-Day RSI : 28.39 (As of May. 28, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Amarantus Bioscience Holdings 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-28), Amarantus Bioscience Holdings's 14-Day RSI is 28.39.

The industry rank for Amarantus Bioscience Holdings's 14-Day RSI or its related term are showing as below:

AMBS's 14-Day RSI is not ranked
in the Biotechnology industry.
Industry Median: 45.2 vs AMBS: 28.39

Competitive Comparison of Amarantus Bioscience Holdings's 14-Day RSI

For the Biotechnology subindustry, Amarantus Bioscience Holdings's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amarantus Bioscience Holdings's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amarantus Bioscience Holdings's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Amarantus Bioscience Holdings's 14-Day RSI falls into.



Amarantus Bioscience Holdings  (OTCPK:AMBS) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amarantus Bioscience Holdings  (OTCPK:AMBS) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Amarantus Bioscience Holdings 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Amarantus Bioscience Holdings's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
45 Wall Street, Suite 920, New York, NY, USA, 10005
Amarantus Bioscience Holdings Inc is a biopharmaceutical company. It is focused on developing therapeutic products for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company's prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia. The group's diagnostics division is dedicated to the development and commercialization of neurology diagnostic products. Its diagnostic product, LymPro Test is a blood-based assay to diagnose Alzheimer's disease.
Executives
Flanigan Conn other: Former Director 1601 BLAKE STREET, SUITE 310, DENVER CO 80202
Robert Edward Farrell officer: CFO BIOVEST INTERNATIONAL, INC., 300 S HYDE PARK AVENUE, SUITE 210, TAMPA FL 33606
Joseph Rubinfeld director C/O SUPERGEN INC, 4140 DUBLIN BLVD STE 200, DUBLIN CA 94568

Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) Headlines

From GuruFocus

Top 5 1st Quarter Trades of Anson Funds Management LP

By GuruFocus Research GuruFocus Editor 05-12-2022

Amarantus Retains Weild & Co. to Advise on JOBS Act Funding

By Marketwired Marketwired 05-22-2018